A-Synaptic Canada Inc.,  A-Synaptic’s first prescription product is the transdermal delivery of cannabidiol for the treatment of childhood epilepsy.  There is a predicate product in the United States, Epidiolex, which orally delivers CBD for the treatment of childhood epilepsy. This means that A-Synaptic is able to use the streamlined 505(b)(2) regulatory pathway to approval.



In addition to epilepsy, other potential treatments include:


  •  fibromyalgia

  • peripheral muscular skeletal pain (osteoarthritis)

  • back pain

  • ulcers (including diabetic foot ulcers and bed sores)



(978) 807-1321


841 Worcester Street, Suite 144, Natick, Massachusetts 01760

Send A Message

Contact Us Online